Moreover, other studies show upregulation of different immune checkpoints like VISTA, TIM-3 and PD-1 in HNSCC and immune cells following irradiation, potentially contributing to immunotherapy efficacy against these targets [54–56]. This evidence concerns the gene VSIR and head and neck squamous cell carcinoma.